Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: David who wrote (17834)	5/8/2000 10:07:00 AM
From: pmcw	Respond to of 26039

IDX BioLogon Ready for Windows 2000 Biometrics Standard Adoption - article linked below. Reading between the lines, the following article really doesn't say much beyond the obvious. The obvious is that MSFT did not adapt the BioAPI standard, that IDX will have to support the MSFT standard and, at least for now, IDX will continue to support BioAPI. It also says what we've been saying which is: A rising tide lifts all ships. The broader the acceptance of biometrics the better. However, this is a game of execution. IDX has won many rounds, but took a solid shot to the jaw in the MSFT deal. Let's see if they can land some punches in the next few rounds; this fight is long from over. biz.yahoo.com Regards, pmcw

To: David who wrote (17834)	5/8/2000 12:18:00 PM
From: DCBEN	Read Replies (1) \| Respond to of 26039

David, I do think you have to read the IDX PR and the WP story on Microsoft's counteroffer together. MSFT has announced a deal with I/O saying they plan to build BAPI into W2K. They have also licensed the secure suite of logon software and presumably they intend to bundle with W2K is some future version. If they do that, it is likely IDX would be forced to give away the basic Biologon software and hope to survive by selling enhanced packages that go beyond what secure suite provides. That's exactly what happened to Netscape. And that is what got MSFT to where it is today: legal hotwater. IDX (and I) must believe that there is no way that MSFT could get away with such a plan now with biometrics. In fact, MSFT is proposing that they foreswear such tactics in writing as part of a settlement with DOJ. What the IDX PR does is says we don't like MSFT trumping BioAPI, which we still support, but regardless of whether they follow through with BAPI or not, we won't be Netscaped. We will develop a Biologon (BAPI version) and we intend to sell it. That puts MSFT on notice that bundling SecureSuite for free as a means of driving them out of business would be a transparent move that will not be allowed by the courts. History won't repeat itself here. MO Ben